Mar 04, 2020 / 02:20PM GMT
Kathleen Marie Miner - Cowen and Company, LLC, Research Division - VP
Good morning, everyone. Welcome to the Elanco presentation. We're very pleased to have Jeff Simmons, CEO of Elanco, joining us today. And as you know from the past couple of days, the animal health is a very exciting space. And so we think Elanco is one of the very exciting ways to participate in, in this segment.
So with that, this is going to be -- we'll do our Q&A, and the company has a breakout session to follow. But please raise your hand for any questions along the way.
Questions and Answers:
Kathleen Marie Miner - Cowen and Company, LLC, Research Division - VPSo Jeff, just to start out, just you've now been public for almost 1.5 years. I think the final spinout was, what, it was March of last year, and fully out of Lilly for a year. Relative to your expectations at this time, what's been the most positive benefit of being a stand-alone company? And what's been the most challenging?
Jeffrey N. Simmons - Elanco Animal Health Incorporated
Trustpilot
